Executive Medical Director, Oncology Clinical Development
Bio
Dr. Jain received her medical degree from Southern Illinois University School of Medicine. She completed her internship and residency in internal medicine at the University of Michigan. She completed her fellowship in hematology and oncology at Weill Cornell Medical College, New York Presbyterian Hospital before joining Northwestern University Feinberg School of Medicine as an Assistant Professor of Medicine.
Dr. Jain’s research focuses on immunotherapy as a complimentary approach for eliminating breast cancer. The success of many treatments, such as chemotherapy and targeted drugs, are limited by resistance and side effects. Her work centers on harnessing the body’s immune system to overcome these barriers.
This new approach, investigated as a Lynn Sage Scholar, entails a bacterial vaccine injected into a metastatic tumor, causing the tumor to deconstruct and generate an immune response to target and eliminate disseminated tumors throughout the body. After impressive results from animal trials, Dr. Jain studied this treatment in women with metastatic breast cancer. She collaborated with her basic science colleagues to improve upon the results and technology in the lab.
Sarika Jain, MD, MS
AbbVie
Newly funded researchers pursuing high-risk, high-reward breast cancer studies in their first or second academic positions.
Past
Early Investigator
Abde Abukhdeir, PhD
The molecular variants that lead or contribute to drug resistance in breast cancer
Past
Early Investigator
Nan Chen, MD
Discovering novel biomarkers of therapy response and resistance in metastatic triple-negative breast cancer patients
Past
Early Investigator
Peiwen Chen, PhD
Targeting macrophage reprogramming in brain metastatic breast cancer
Why your gift matters
Your gift helps researchers test bold ideas, generate critical data, and take the first steps toward the next major advancement in breast cancer treatment and care.Together, we can accelerate discoveries that save lives.
